long-term follow-up results for murano trial in cll
Published 5 years ago • 283 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
5:35
murano trial and time-limited therapies
-
1:36
follow-up shows venetoclax plus rituximab has long-term efficacy in cll
-
2:13
venetoclax rituximab for r/r cll: 7-year results of the murano trial
-
0:41
reviewing key points from the phase iii murano trial in cll
-
7:07
murano trial: sustained disease survival in cll following venetoclax plus rituximab
-
0:51
long-term post hoc analysis of murano trial: host immune changes following venr treatment in cll
-
6:25
murano: five-year follow-up on venetoclax plus rituximab for cll
-
3:12
results of the murano study for cll
-
3:46
long-term follow-up of venetoclax in cll
-
1:44
dr. lamanna discusses the murano trial in cll
-
8:58
venetoclax plus rituximab in relapsed/refractory cll
-
8:16
optimizing frontline therapy selection and follow-up in cll
-
6:42
venetoclax rituximab in relapsed cll
-
2:04
murano trial: revolutionizing the standard of care for relapsed cll patients
-
5:04
targeted therapy options for frontline cll
-
2:13
long term results with venetoclax for cll is very promising
-
8:20
venetoclax & rituximab vs. bendamustine & rituximab treatment for chronic lymphocytic leukemia (cll)
-
3:13
long-term follow-up of the gaia/cll13 trial: investigating venetoclax-containing combinations in cll
-
6:13
murano trial update in r/r cll